Pembrolizumab, Larotrectinib Point to Future of Precision Medicine

With the examples of pembrolizumab and larotrectinib, Dr Markman discusses how precision cancer medicine will likely change the landscape of cancer therapy.
Source: Medscape Oncology - Category: Cancer & Oncology Authors: Source Type: podcasts